Mohammed Imran Khan

The exciting possibilities of scientific discovery with cutting-edge multi-omics and stem cell technology is evident in the breadth of our research. From decoding genetic variants to discovering new biomarkers for cancer, from identifying novel targets for cancer immunotherapy to developing disease models derived from stem-cells - we aim to accelerate Saudi Arabia’s leadership in molecular medicine, fostering clinical translation and local capacity in omics-driven patient care.